SNDL (SNDL) stock gains as the company reports Q4 2024 revenue growth driven by its Cannabis Retail business. Read more here.

Operator Hello, everyone, and welcome to SNDL fourth quarter 2024 results conference call. At this time, all participants are ...

Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

The fund posted returns of-0.35%(Institutional shares) and-0.51%(Investor A shares, without sales charge) for the fourth ...